VEGF acts as a potent angiogenic inducer during tumor progression and metastasis and binds to tyrosine kinase receptors, including VEGFR1 or VEGFR2, on the vascular endothelial cell surface [102]. This evidence concerns the gene NTRK1 and neoplasm.